Terms: = Germ cell tumor AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1
98400 results:
1. A longer time to relapse is associated with a larger increase in differences between paired primary and recurrent IDH wild-type glioblastomas at both the transcriptomic and genomic levels.
Ho WM; Chen CY; Chiang TW; Chuang TJ
Acta Neuropathol Commun; 2024 May; 12(1):77. PubMed ID: 38762464
[TBL] [Abstract] [Full Text] [Related]
2. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
[TBL] [Abstract] [Full Text] [Related]
3. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
Miao L; Miao T; Zhang Y; Hao J
BMC Cancer; 2024 May; 24(1):602. PubMed ID: 38760735
[TBL] [Abstract] [Full Text] [Related]
4. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
[TBL] [Abstract] [Full Text] [Related]
5. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
6. Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.
Abdouh S; Boujguenna I; Soleh A; Abkari I; Rais H
J Med Case Rep; 2024 May; 18(1):249. PubMed ID: 38755643
[TBL] [Abstract] [Full Text] [Related]
7. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
8. Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
Gargett T; Truong NTH; Gardam B; Yu W; Ebert LM; Johnson A; Yeo ECF; Wittwer NL; Tapia Rico G; Logan J; Sivaloganathan P; Collis M; Ruszkiewicz A; Brown MP
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754916
[TBL] [Abstract] [Full Text] [Related]
9. PRESOLRE: study protocol for a primary school-based, cluster randomised controlled trial of three sun exposure risk prevention strategies on Reunion Island.
Dugast C; Bruneau L; Fianu A; Ferdynus C; Boussaid K; Vuichard J; Duloutre F; Dumez J; Sultan-Bichat N; Bertolotti A
BMJ Open; 2024 May; 14(5):e082045. PubMed ID: 38754877
[TBL] [Abstract] [Full Text] [Related]
10. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
[TBL] [Abstract] [Full Text] [Related]
11. Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.
Bonfiglio F; Lasorsa VA; Aievola V; Cantalupo S; Morini M; Ardito M; Conte M; Fragola M; Eva A; Corrias MV; Iolascon A; Capasso M
HLA; 2024 May; 103(5):e15515. PubMed ID: 38747019
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
[TBL] [Abstract] [Full Text] [Related]
13. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma.
Thongkumkoon P; Sangphukieo A; Tongjai S; Noisagul P; Sangkhathat S; Laochareonsuk W; Kamolphiwong R; Budprom P; Teeyakasem P; Yongpitakwattana P; Thepbundit V; Sirikaew N; Klangjorhor J; Settakorn J; Moonmuang S; Suksakit P; Pasena A; Chaijaruwanich J; Yathongkhum W; Dissook S; Pruksakorn D; Chaiyawat P
Sci Rep; 2024 May; 14(1):11056. PubMed ID: 38744935
[TBL] [Abstract] [Full Text] [Related]
14. Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma.
Ji Q; McAfee SS; Scoggins M; Holtrop J; Glass JO; Yuan X; Liang J; Li Y; Chiang J; Orr BA; Edwards A; Storment D; Brinkman T; Robinson GW; Gajjar A; Reddick WE; Patay Z; Khan RB; Bag AK
Radiology; 2024 May; 311(2):e232521. PubMed ID: 38742969
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analysis of clinical images contributions for melanoma classification using convolutional neural networks.
Rios-Duarte JA; Diaz-Valencia AC; Combariza G; Feles M; Peña-Silva RA
Skin Res Technol; 2024 May; 30(5):e13607. PubMed ID: 38742379
[TBL] [Abstract] [Full Text] [Related]
16. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
[TBL] [Abstract] [Full Text] [Related]
17. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract] [Full Text] [Related]
18. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
19. Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy.
Halpert MM; Burns BA; Rosario SR; Withers HG; Trivedi AJ; Hofferek CJ; Gephart BD; Wang H; Vazquez-Perez J; Amanya SB; Hyslop ST; Yang J; Kemnade JO; Sandulache VC; Konduri V; Decker WK
FASEB J; 2024 May; 38(10):e23644. PubMed ID: 38738472
[TBL] [Abstract] [Full Text] [Related]
20. [Multiple ileal neuroendocrine tumors 10mm in diameter with lymph node metastasis detected on endoscopy:a case report].
Nimura Y; Hamajima E; Nakae Y; Kamioka T; Nakashima S; Kuno T; Ito M
Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):389-399. PubMed ID: 38735747
[TBL] [Abstract] [Full Text] [Related]
[Next]